MariMed Statistics
Total Valuation
MariMed has a market cap or net worth of 33.04 million. The enterprise value is 125.74 million.
| Market Cap | 33.04M |
| Enterprise Value | 125.74M |
Important Dates
The last earnings date was Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MariMed has 395.25 million shares outstanding. The number of shares has increased by 2.31% in one year.
| Current Share Class | 395.07M |
| Shares Outstanding | 395.25M |
| Shares Change (YoY) | +2.31% |
| Shares Change (QoQ) | +0.70% |
| Owned by Insiders (%) | 10.47% |
| Owned by Institutions (%) | 0.25% |
| Float | 353.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.21 |
| PB Ratio | 0.48 |
| P/TBV Ratio | 2.14 |
| P/FCF Ratio | 19.89 |
| P/OCF Ratio | 8.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.46, with an EV/FCF ratio of 75.70.
| EV / Earnings | -7.06 |
| EV / Sales | 0.80 |
| EV / EBITDA | 8.46 |
| EV / EBIT | 116.21 |
| EV / FCF | 75.70 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 1.25.
| Current Ratio | 1.06 |
| Quick Ratio | 0.26 |
| Debt / Equity | 1.25 |
| Debt / EBITDA | 5.81 |
| Debt / FCF | 52.02 |
| Interest Coverage | 0.15 |
Financial Efficiency
Return on equity (ROE) is -22.81% and return on invested capital (ROIC) is 0.41%.
| Return on Equity (ROE) | -22.81% |
| Return on Assets (ROA) | 0.32% |
| Return on Invested Capital (ROIC) | 0.41% |
| Return on Capital Employed (ROCE) | 0.73% |
| Revenue Per Employee | 203,333 |
| Profits Per Employee | -23,019 |
| Employee Count | 832 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 2.59 |
Taxes
In the past 12 months, MariMed has paid 11.23 million in taxes.
| Income Tax | 11.23M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.81% in the last 52 weeks. The beta is 1.00, so MariMed's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -43.81% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 34.96 |
| Average Volume (20 Days) | 1,216,665 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, MariMed had revenue of 157.38 million and -17.82 million in losses. Loss per share was -0.05.
| Revenue | 157.38M |
| Gross Profit | 60.29M |
| Operating Income | 1.08M |
| Pretax Income | -6.55M |
| Net Income | -17.82M |
| EBITDA | 12.75M |
| EBIT | 1.08M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 6.60 million in cash and 86.40 million in debt, giving a net cash position of -79.80 million or -0.20 per share.
| Cash & Cash Equivalents | 6.60M |
| Total Debt | 86.40M |
| Net Cash | -79.80M |
| Net Cash Per Share | -0.20 |
| Equity (Book Value) | 69.05M |
| Book Value Per Share | 0.14 |
| Working Capital | 3.51M |
Cash Flow
In the last 12 months, operating cash flow was 3.85 million and capital expenditures -2.19 million, giving a free cash flow of 1.66 million.
| Operating Cash Flow | 3.85M |
| Capital Expenditures | -2.19M |
| Free Cash Flow | 1.66M |
| FCF Per Share | 0.00 |
Margins
Gross margin is 38.31%, with operating and profit margins of 0.69% and -11.32%.
| Gross Margin | 38.31% |
| Operating Margin | 0.69% |
| Pretax Margin | -4.16% |
| Profit Margin | -11.32% |
| EBITDA Margin | 8.10% |
| EBIT Margin | 0.69% |
| FCF Margin | 1.06% |
Dividends & Yields
MariMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.31% |
| Shareholder Yield | -2.31% |
| Earnings Yield | -53.92% |
| FCF Yield | 5.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MariMed has an Altman Z-Score of 0.16 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.16 |
| Piotroski F-Score | 4 |